Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Plenty of comparisons have been made in recent years between fast-developing artificial intelligence systems and HAL, the rogue computer in Stanley Kubrick’s “2001: A Space Odyssey” that operated by ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Ginkgo Bioworks has pivoted to autonomous lab infrastructure in an attempt to capitalize on emerging AI tailwinds. Read more ...
Alphabet high CapEx spending is prudent given the all-or-nothing nature of the AI race, with data centers retaining value.
Microsoft Threat Intelligence observed a human-operated intrusion campaign that abuses Microsoft Teams external collaboration to impersonate IT support, gain remote access, and deploy a Node.js-based ...
Microsoft Threat Intelligence provides analysis of a ClickFix campaign that uses fake CAPTCHA prompts, DLL sideloading, and a reverse tunnel, with detections and hunting guidance.
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results